Background/Purpose: immunosuppressive therapies and bDAMRDs expecially, increase the risk of infections. According to the EULAR guidelines, all patients affected by autoimmune/inflammatory diseases should receive vaccinations against influenza and pneumococcus. The primary aim of this work is to evaluate the prevalence of flu and pneumococcal vaccinations in a cohort of patients affected by inflammatory arthritides and SLE treated with biological drugs. The secondary aim was to explore the reason why patients do not receive vaccination. Methods: we administered a self-reporting questionnaire about both flu and pneumococcal vaccination, to 274 consecutive patients from February to April 2017 treated with bDMARDs. Results: the 65.3% of patients declared to have been informed from rheumatologist about the possibility to received vaccinations during biological treatments but the 19.5% declared to have never been informed about them. The 46% of patients vaccination for influenza was performed after rheumatology suggestion and the 21% after their general pratictioner suggestion, while the 30.1% has declared to have not performed it for several reasons: because concerned about adverse events (5.1%), beacause they don’t see it as useful (17.4%) or for other reasons. The injection has been administered for free in the majority of patients (GPs 36.8%, local healthcare 33.5%). The 60.9% would have undergone vaccination even for a fee. The anti pneumococcal vaccination was administered to the 25.3%, while to the 50.3% has never been suggested to do it. The 4.4% has declared to have not performed it because concerned about adverse events and the 6.6% because they don’t see it as useful. The injection has been administered for free at local healthcare facilities in the 84% of the patients. The 97.3% would have undergone vaccination even for a fee. At last the patients have declared to have always been well informed about vaccinations (48,9%), to have been well informed only about certain vaccinations (9,5%) or to have been informed only after asking (9,1%); The 19.1% was unsatisfied. Conclusion: the acquired vaccine rate has been low for the influenza vaccination (<60%) and extremely low for the pneumococcal vaccination (26%). Even if the reasons of this results are partially attributable to a low patients’ compliance (47.5% for the influenza vaccination, 11% for the anti pneumococcical vaccination), almost 20% has declared not to have ever been informed about vaccinations. So an additional effort to improve these results is mandatory.

Reasons Why Patients Failed Vaccinations Vs Influenza and Pneumococcus. Monocentric Cross-Sectional Study

Talotta, R;
2017-01-01

Abstract

Background/Purpose: immunosuppressive therapies and bDAMRDs expecially, increase the risk of infections. According to the EULAR guidelines, all patients affected by autoimmune/inflammatory diseases should receive vaccinations against influenza and pneumococcus. The primary aim of this work is to evaluate the prevalence of flu and pneumococcal vaccinations in a cohort of patients affected by inflammatory arthritides and SLE treated with biological drugs. The secondary aim was to explore the reason why patients do not receive vaccination. Methods: we administered a self-reporting questionnaire about both flu and pneumococcal vaccination, to 274 consecutive patients from February to April 2017 treated with bDMARDs. Results: the 65.3% of patients declared to have been informed from rheumatologist about the possibility to received vaccinations during biological treatments but the 19.5% declared to have never been informed about them. The 46% of patients vaccination for influenza was performed after rheumatology suggestion and the 21% after their general pratictioner suggestion, while the 30.1% has declared to have not performed it for several reasons: because concerned about adverse events (5.1%), beacause they don’t see it as useful (17.4%) or for other reasons. The injection has been administered for free in the majority of patients (GPs 36.8%, local healthcare 33.5%). The 60.9% would have undergone vaccination even for a fee. The anti pneumococcal vaccination was administered to the 25.3%, while to the 50.3% has never been suggested to do it. The 4.4% has declared to have not performed it because concerned about adverse events and the 6.6% because they don’t see it as useful. The injection has been administered for free at local healthcare facilities in the 84% of the patients. The 97.3% would have undergone vaccination even for a fee. At last the patients have declared to have always been well informed about vaccinations (48,9%), to have been well informed only about certain vaccinations (9,5%) or to have been informed only after asking (9,1%); The 19.1% was unsatisfied. Conclusion: the acquired vaccine rate has been low for the influenza vaccination (<60%) and extremely low for the pneumococcal vaccination (26%). Even if the reasons of this results are partially attributable to a low patients’ compliance (47.5% for the influenza vaccination, 11% for the anti pneumococcical vaccination), almost 20% has declared not to have ever been informed about vaccinations. So an additional effort to improve these results is mandatory.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/3149498
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact